A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT00880217 · COMPLETED

Trial details

NCT number: NCT00880217
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2009-05-01
Primary completion: 2010-01-01
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.